After careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, STORM Therapeutics has made the decision not to travel for the foreseeable future to upcoming events & conferences. We remain focused on supporting the wellbeing and safety of our staff.
STORM is open to collaboration opportunities to discover and validate new RNA Modifying Enzyme (RME) targets and to explore utilising our first in class inhibitors in new therapeutic applications. If you would like to learn more, want to join us, partner or collaborate, please contact email@example.com
Thank you and best wishes through this period.